Evidence map›Paper›PMID 32020866›Full record

ArticleBMC complementary medicine and therapies2020

Medicinal plants sold for treatment of bacterial and parasitic diseases in humans in Maputo city markets, Mozambique.

Filomena Barbosa, Delfina Hlashwayo, Victor Sevastyanov, Valeriano Chichava, Adilência Mataveia, Ernesto Boane, Aida Cala

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Mixed methods research in complementary and alternative medicine: a scoping review.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2022
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Filomena BarbosaDepartamento de Ciências Biológicas, Faculdade de Ciências, Universidade Eduardo Mondlane, Avenida Julius Nyerere nr 3453, Campus Principal, Maputo, Mozambique. filomena.barbosa97@gmail.com.ORCID http://orcid.org/0000-0002-1932-529X
Delfina HlashwayoDepartamento de Ciências Biológicas, Faculdade de Ciências, Universidade Eduardo Mondlane, Avenida Julius Nyerere nr 3453, Campus Principal, Maputo, Mozambique.
Victor SevastyanovDepartamento de Química, Faculdade de Ciências, Universidade Eduardo Mondlane, Avenida Julius Nyerere nr 3453, Campus Principal, Maputo, Mozambique.
Valeriano ChichavaDepartamento de Ciências Biológicas, Faculdade de Ciências, Universidade Eduardo Mondlane, Avenida Julius Nyerere nr 3453, Campus Principal, Maputo, Mozambique.
Adilência MataveiaDepartamento de Ciências Biológicas, Faculdade de Ciências, Universidade Eduardo Mondlane, Avenida Julius Nyerere nr 3453, Campus Principal, Maputo, Mozambique.
Ernesto BoaneDepartamento de Ciências Biológicas, Faculdade de Ciências, Universidade Eduardo Mondlane, Avenida Julius Nyerere nr 3453, Campus Principal, Maputo, Mozambique.
Aida CalaDirecção de Ciências Animais, Instituto de Investigação Agrária de Moçambique, Avenida de Moçambique Km 1.5, Maputo, Mozambique.
Eduardo Mondlane University · MZInstituto de Investigação Agrária de Moçambique · MZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Mozambique, bacterial and parasitic diseases contribute to a high burden of mortality and morbidity. These infectious diseases are treated with antibiotics, antihelmintic or antiparasitic drugs. However, misuse of these has been affecting the potential to treat ailments. It has been reported that many people from Maputo city and province apart from the existing contemporary medicine, still use medicinal plants for treatment of diseases due to traditional heritage and beliefs. It is, therefore, important to register this knowledge in order to use it for future pharmacological studies. This study aimed to identify the medicinal plants sold in Xipamanine, Xiquelene and Mazambane markets for treatment of bacterial and parasitic diseases.

methodsAn ethnobotanical survey, using interviews, was conducted to the main vendors of the markets. Data about the plant name, part used, mode of preparation and administration route were collected.

resultsA total of 64 medicinal plants belonging to 32 families were listed as sold for treatment of bacterial and parasitic diseases in the three markets. Terminalia sericea, Elephantorrhiza elephantina, Tiliacora funifera and Hypoxis hemerocallidea were the most cited plants. Roots were the most often sold suggesting it is the most used part. We also found out that medicinal plants trade is still common in Maputo markets. This suggests that people still use plant-based herbal medicines for their basic health care.

conclusionsSeveral medicinal plants were sold in Maputo city's markets for treatment of bacterial and parasitic diseases, with more emphasis on diarrhea and helminthiases. These plants were commonly bought by local residents and play an important role in the subsistence of vendors. Pharmacological studies are needed in order to isolate the plants active principles and understand their mechanism of action, so that new drugs can be developed.

Indexed as

CommerceMedicine, African TraditionalAdultBacterial InfectionsEthnobotanyFemaleHumansMaleMiddle AgedMozambiqueParasitic DiseasesPlants, MedicinalMaputomarketsMedicinal plantsMozambique

Identifiers

PMID32020866
PMCPMC7076832
OpenAlexW3003149372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.